Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530627) titled 'Efficacy of UMT in CG Patients With PL' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Peking University First Hospital
Condition:
Pelvic Lipomatosis
Cystitis Glandularis
Intervention:
Biological: Urinary Microbiota Transplantation (UMT)
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: February 1, 2025
Target Sample Size: 110
Countries of Recruitment:
China
To know more, visit ht...